Equillium Statistics
Total Valuation
Equillium has a market cap or net worth of $17.94 million. The enterprise value is -$4.25 million.
Important Dates
The last earnings date was Thursday, March 27, 2025, before market open.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Equillium has 35.61 million shares outstanding. The number of shares has increased by 1.82% in one year.
| Current Share Class | 35.43M |
| Shares Outstanding | 35.61M |
| Shares Change (YoY) | +1.82% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 19.66% |
| Owned by Institutions (%) | 6.85% |
| Float | 18.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.34 |
| Forward PS | n/a |
| PB Ratio | 0.73 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.93 |
| Quick Ratio | 3.73 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.75% and return on invested capital (ROIC) is -24.13%.
| Return on Equity (ROE) | -38.75% |
| Return on Assets (ROA) | -13.58% |
| Return on Invested Capital (ROIC) | -24.13% |
| Return on Capital Employed (ROCE) | -42.96% |
| Revenue Per Employee | $933,977 |
| Profits Per Employee | -$183,341 |
| Employee Count | 44 |
| Asset Turnover | 1.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Equillium has paid $361,000 in taxes.
| Income Tax | 361,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.19% in the last 52 weeks. The beta is 1.87, so Equillium's price volatility has been higher than the market average.
| Beta (5Y) | 1.87 |
| 52-Week Price Change | -78.19% |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 0.80 |
| Relative Strength Index (RSI) | 35.32 |
| Average Volume (20 Days) | 149,834 |
Short Selling Information
The latest short interest is 363,002, so 1.02% of the outstanding shares have been sold short.
| Short Interest | 363,002 |
| Short Previous Month | 363,929 |
| Short % of Shares Out | 1.02% |
| Short % of Float | 2.02% |
| Short Ratio (days to cover) | 4.02 |
Income Statement
In the last 12 months, Equillium had revenue of $41.10 million and -$8.07 million in losses. Loss per share was -$0.23.
| Revenue | 41.10M |
| Gross Profit | 41.10M |
| Operating Income | -8.27M |
| Pretax Income | -7.81M |
| Net Income | -8.07M |
| EBITDA | -8.13M |
| EBIT | -8.27M |
| Loss Per Share | -$0.23 |
Full Income StatementBalance Sheet
The company has $22.58 million in cash and $384,000 in debt, giving a net cash position of $22.19 million or $0.62 per share.
| Cash & Cash Equivalents | 22.58M |
| Total Debt | 384,000 |
| Net Cash | 22.19M |
| Net Cash Per Share | $0.62 |
| Equity (Book Value) | 19.06M |
| Book Value Per Share | 0.54 |
| Working Capital | 18.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.03 million and capital expenditures -$85,000, giving a free cash flow of -$19.11 million.
| Operating Cash Flow | -19.03M |
| Capital Expenditures | -85,000 |
| Free Cash Flow | -19.11M |
| FCF Per Share | -$0.54 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -20.12% and -19.63%.
| Gross Margin | 100.00% |
| Operating Margin | -20.12% |
| Pretax Margin | -18.75% |
| Profit Margin | -19.63% |
| EBITDA Margin | -19.79% |
| EBIT Margin | -20.12% |
| FCF Margin | n/a |
Dividends & Yields
Equillium does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.82% |
| Shareholder Yield | -1.82% |
| Earnings Yield | -44.97% |
| FCF Yield | -106.53% |
Analyst Forecast
The average price target for Equillium is $3.00, which is 495.47% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.00 |
| Price Target Difference | 495.47% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 24.09% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Equillium has an Altman Z-Score of -5.31. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.31 |
| Piotroski F-Score | n/a |